معرفی
Joseph Brito III, MD, is an Associate Professor on Term in the Department of Urology at Yale School of Medicine. He provides general urologic care with a focus on urologic oncology, specializing in minimally invasive and robotic surgical techniques for prostate, bladder, and kidney cancers at Lawrence & Memorial Hospital in New London, part of Yale New Haven Health. He is board certified by the American Board of Urology and a member of the American Urological Association.
- BA in Philosophy with Pre-Med Track, Middlebury College (2006)
- MD, George Washington University School of Medicine and Health Sciences (2012)
- Internship, Rhode Island Hospital/Alpert Medical School of Brown University (2013)
- Residency in Urology, Rhode Island Hospital/Alpert Medical School of Brown University (2017)
- Fellowship in Clinical Oncology, Yale School of Medicine (2018)
Dr. Brito's research focuses on advancing diagnostic and therapeutic strategies in urologic cancers, particularly prostate cancer. His work emphasizes image-guided biopsy techniques (including micro-ultrasound and MRI fusion), surgical outcomes, and novel interventions such as nutritional approaches using fermented soy. He is actively involved in clinical trials and translational research aimed at improving cancer detection, risk stratification, and patient outcomes.
His recent publications highlight trends in precision urologic oncology, including comparative effectiveness of biopsy modalities, prognostic factors for Gleason upgrading, and management of radio-recurrent disease. A significant portion of his research involves collaborative, multi-investigator studies published in leading journals such as JAMA, The Journal of Urology, and Urologic Oncology.
- 2024 'Top Doctors' List by Yale Medicine
- 2023 'Top Doctors' List by Yale Medicine
Dr. Brito is an active clinician-scientist and educator at Yale School of Medicine. He mentors trainees and contributes to the academic mission through research collaborations, particularly within the Yale Cancer Center and Urology Department. His clinical practice and research are integrated within multidisciplinary programs such as the Prostate & Urologic Cancers Program and the Benign Prostatic Hyperplasia Program. He has not publicly listed any formal advisees or independent grant funding, but his frequent co-authorship with senior faculty indicates strong integration within research teams.
